Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer

NCT03071198 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT03071198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2017
Completion date
September 30, 2021
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectum cancer